Correlation between right ventricular indices and clinical improvement in epoprostenol treated pulmonary hypertension patients

Echocardiography

Volumn 22, Issue 5, 2005, Pages 374-379

  Nath, Jayant ^a,d   DeMarco, Teresa ^b   Hourigan, Lisa ^b   Heidenreich, Paul A ^c   Foster, Elyse ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d NONE   (United States)

Author keywords

Epoprostenol; Myocardial performance index; Pulmonary hypertension; Right ventricular function

Indexed keywords

PROSTACYCLIN;

ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART INDEX; HEART PERFORMANCE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE EJECTION; HUMAN; LUNG ARTERY PRESSURE; LUNG RESISTANCE; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RADIODIAGNOSIS; TRICUSPID VALVE REGURGITATION;

ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; EPOPROSTENOL; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; OBSERVER VARIATION; PROGNOSIS; PULMONARY VALVE; PULMONARY WEDGE PRESSURE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR FUNCTION, RIGHT;

EID: 18744395217     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2005.04022.x     Document Type: Article

References (20)

1. Tei C, Dujardin KS, Hodge DO, et al: Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996;9:838-847.
2. Scapellato F, Temporelli PL, Eleuteri E, et al: Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic heart failure. J Am Coll Cardiol 2001;37:1813-1819.
3. Shandas R, Weinberg C, Ivy DD, et al: Development of a noninvasive ultrasound color M-mode means of estimating pulmonary vascular resistance in pediatric pulmonary hypertension: Mathematical analysis, in vitro validation, and preliminary clinical studies. Circulation 2001;104:908-913.
4. Abbas AE, Fortuin FD, Schiller NB, et al: A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 2003;19:1021-1027.
5. Barst RJ, Rubin LJ, Long WA, et al: A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The primary pulmonary hypertension study group. N Engl J Med 1996;334:296-302.
6. Barst RJ, Rubin LJ, McGoon MD, et al: Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 1994;121:409-415.
7. Krowka MJ, Frantz RP, McGoon MD, et al: Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 1999;30:641-648.
8. Hinderliter AL, Willis PW 4th, Barst RJ, et al: Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 1997;95:1479-1486.
9. Baim DS, Grossman W: Grossman's Cardiac Catheterization, Angiography and Intervention, 6th Ed. Philadelphia, Lippincott Williams & Wilkins, 2000, p. 171.
10. Rich S: Executive Summary from the World Symposium on Primary Pulmonary Hypertension Evian, France, September 6-10, 1998.
11. Rubin LJ: Primary pulmonary hypertension. N Engl J Med 1997;336(2):111-117.
12. Otto C: Textbook of Clinical Echocardiography, 2nd Ed. Philadelphia, W B Saunders, 2000, p. 121.
13. Kaul S, Tei C, Hopkins JM, et al: Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J 1984;107:526-531.
14. Kircher BJ, Himelman RB, Schiller NB: Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990;66:493-496.
15. Yock PG, Popp RL: Noninvasive estimation of right ventricular systolic pressure by Doppler Ultrasound in patients with tricuspid regurgitation. Circulation 1984;70:657-662.
16. Currie PJ, Seward JB, Chart KL, et al: Continuous wave Doppler determination of right ventricular pressure: A simultaneous Doppler- catheterization study in 127 patients. J Am Coll Cardiol 1985;6:750-756.
17. Montalescot G, Drobinski G, Meurin P, et al: Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol 1998;82(6):749-755.
18. Rich S, McLaughlin VV: The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. J Am Coll Cardiol 1999;34:1184-1187.
19. McLaughlin VV, Genuiner DE, Panella MM, et al: Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998;338(5):273-277.
20. Galie N, Manes A, Branzi A: Medical therapy of pulmonary hypertension. Clin Chest Med 2001;22:529-537.